Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Futura MedicalSTU:GYX EV-to-FCF is 0.23 as of Jul. 15, 2026. The stock has 5 warning signs investors should review. Among 336 Biotechnology companies, Futura Medical ranks better than 90.48% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Futura Medical's Enterprise Value is €-1.52 Mil.
Futura Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-6.52 Mil. Therefore, Futura Medical's EV-to-FCF for today is 0.23.
The historical rank and industry rank for Futura Medical's EV-to-FCF or its related term are showing as below:
STU:GYX'
s EV-to-FCF Range Over the Past 10 Years
Min: -134.49 Med: -7.95 Max: 2.56
Current: 0.22
During the past 13 years, the highest EV-to-FCF of Futura Medical was 2.56. The lowest was -134.49. And the median was -7.95.
STU:GYX's EV-to-FCF is ranked better than 90.48% of 336
companies
in the Biotechnology industry
Industry Median: 15.32
vs STU:GYX: 0.22
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Futura Medical's PE Ratio (TTM) for today is calculated as:
Futura Medical's share price for today is €0.0005.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Futura Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.033.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Futura Medical EV-to-FCF Related Terms
Futura Medical EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Futura Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Futura Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Futura Medical EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Futura Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Futura Medical's EV-to-FCF falls into.
Futura Medical's current Enterprise Value is €-1.52 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Futura Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-6.52 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Futura Medical (STU:GYX) has a EV-to-FCF of 0.23 as of Jul. 15, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Futura Medical and its competitors. According to the industry distribution chart, Futura Medical ranks #32 out of 336 companies in the Biotechnology industry, placing it in the top 9.5%.
Is Futura Medical's EV-to-FCF too high?
Futura Medical's current EV-to-FCF is 0.23. The Biotechnology industry median EV-to-FCF is 15.32. Futura Medical's value of 0.23 is 98.5% below this industry median. Based on the distribution chart, Futura Medical ranks #32 out of 336 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Futura Medical's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Futura Medical ranks #32 out of 336 companies for EV-to-FCF. This places Futura Medical in the top 10% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 15.32. Futura Medical's value of 0.23 is 98.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.32, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Futura Medical's current EV-to-FCF of 0.23 is 98.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Futura Medical and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Futura Medical's current EV-to-FCF is 0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Futura Medical stock overvalued right now?
Futura Medical (STU:GYX) has a current EV-to-FCF of 0.23. The current EV-to-FCF is 0.23 and 98.5% below the Biotechnology industry median of 15.32. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Futura Medical (STU:GYX), the current EV-to-FCF is 0.23 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives the majority of its revenue from the United Kingdom and the European Union.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:GYX has been successfully added to your 
